Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer

NCT00786552 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Cancer

Interventions

DRUG: pemetrexed + paclitaxel

Sponsor

University Hospital Schleswig-Holstein